PL2264009T3 - Związek stanowiący kwas pirydyloaminooctowy - Google Patents
Związek stanowiący kwas pirydyloaminooctowyInfo
- Publication number
- PL2264009T3 PL2264009T3 PL09721163T PL09721163T PL2264009T3 PL 2264009 T3 PL2264009 T3 PL 2264009T3 PL 09721163 T PL09721163 T PL 09721163T PL 09721163 T PL09721163 T PL 09721163T PL 2264009 T3 PL2264009 T3 PL 2264009T3
- Authority
- PL
- Poland
- Prior art keywords
- acid compound
- pyridylaminoacetic acid
- pyridylaminoacetic
- compound
- acid
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008062926 | 2008-03-12 | ||
| PCT/JP2009/054713 WO2009113600A1 (ja) | 2008-03-12 | 2009-03-12 | ピリジルアミノ酢酸化合物 |
| EP09721163.5A EP2264009B1 (en) | 2008-03-12 | 2009-03-12 | Pyridylaminoacetic acid compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2264009T3 true PL2264009T3 (pl) | 2019-07-31 |
Family
ID=41065261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09721163T PL2264009T3 (pl) | 2008-03-12 | 2009-03-12 | Związek stanowiący kwas pirydyloaminooctowy |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8648097B2 (pl) |
| EP (1) | EP2264009B1 (pl) |
| JP (3) | JP5136640B2 (pl) |
| KR (1) | KR101609001B1 (pl) |
| CN (2) | CN101970410B (pl) |
| AU (1) | AU2009224329B2 (pl) |
| CA (1) | CA2718393C (pl) |
| CY (1) | CY1121543T1 (pl) |
| DK (1) | DK2264009T3 (pl) |
| ES (1) | ES2718813T3 (pl) |
| HR (1) | HRP20190509T1 (pl) |
| HU (1) | HUE042839T2 (pl) |
| LT (1) | LT2264009T (pl) |
| PL (1) | PL2264009T3 (pl) |
| PT (1) | PT2264009T (pl) |
| SI (1) | SI2264009T1 (pl) |
| TR (1) | TR201904655T4 (pl) |
| WO (1) | WO2009113600A1 (pl) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8648097B2 (en) * | 2008-03-12 | 2014-02-11 | Ube Industries, Ltd. | Pyridylaminoacetic acid compound |
| ES2564010T3 (es) * | 2009-03-30 | 2016-03-17 | Ube Industries, Ltd. | Composición farmacéutica para tratar o prevenir el glaucoma |
| WO2011030865A1 (ja) * | 2009-09-11 | 2011-03-17 | 宇部興産株式会社 | 置換ベンジル化合物 |
| JP2011057633A (ja) * | 2009-09-11 | 2011-03-24 | Ube Industries Ltd | ピリジルアミノ酢酸化合物を含有する医薬 |
| JPWO2011030864A1 (ja) * | 2009-09-11 | 2013-02-07 | 宇部興産株式会社 | アニリン化合物 |
| EP2476678A4 (en) * | 2009-09-11 | 2013-02-20 | Ube Industries | SUBSTITUTED CARBONYL COMPOUNDS |
| WO2011030873A1 (ja) * | 2009-09-11 | 2011-03-17 | 宇部興産株式会社 | ベンジル化合物 |
| WO2011030871A1 (ja) * | 2009-09-11 | 2011-03-17 | 宇部興産株式会社 | Ｎ－置換ヘテロアリール化合物 |
| WO2011030872A1 (ja) * | 2009-09-11 | 2011-03-17 | 宇部興産株式会社 | スルホンアミド化合物 |
| WO2011078303A1 (ja) | 2009-12-25 | 2011-06-30 | 宇部興産株式会社 | アミノピリジン化合物 |
| AU2011225122B8 (en) * | 2010-03-12 | 2013-12-12 | Nippon Soda Co., Ltd. | Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative |
| AR080684A1 (es) * | 2010-03-18 | 2012-05-02 | Bayer Cropscience Ag | Aril- y hetarilsulfonamidas como sustancias activas contra un estres abiotico de plantas |
| EP2471363A1 (de) | 2010-12-30 | 2012-07-04 | Bayer CropScience AG | Verwendung von Aryl-, Heteroaryl- und Benzylsulfonamidocarbonsäuren, -carbonsäureestern, -carbonsäureamiden und -carbonitrilen oder deren Salze zur Steigerung der Stresstoleranz in Pflanzen |
| RU2015145989A (ru) * | 2013-03-28 | 2017-05-16 | Убе Индастриз, Лтд. | Замещенное биарильное соединение |
| US20160213657A1 (en) | 2013-09-02 | 2016-07-28 | Ube Industries, Ltd. | Pharmaceutical composition for treatment and/or prevention of pulmonary disease |
| BR112016015909B1 (pt) | 2014-01-10 | 2020-09-29 | Santen Pharmaceutical Co., Ltd. | Composição farmacêutica contendo composto de ácido piridilaminoacético |
| CA2934612C (en) * | 2014-01-10 | 2021-09-07 | Santen Pharmaceutical Co., Ltd. | Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical composition |
| EP3424503B1 (en) * | 2014-01-10 | 2020-09-02 | Santen Pharmaceutical Co., Ltd | Pharmaceutical preparation including pyridylamino acetic acid compound |
| KR102374969B1 (ko) * | 2014-06-10 | 2022-03-16 | 우베 고산 가부시키가이샤 | 헤테로 방향족 술폰아미드 화합물의 제조 방법 |
| US10774072B2 (en) * | 2014-06-10 | 2020-09-15 | Ube Industries, Ltd. | Crystal of N-substituted sulfonamide compound |
| CA2951784C (en) | 2014-06-10 | 2022-05-31 | Ube Industries, Ltd. | N-substituted sulfonamide compound and method for producing same |
| JP2017206445A (ja) * | 2014-09-26 | 2017-11-24 | 宇部興産株式会社 | 呼吸器疾患の治療及び／又は予防のための医薬組成物 |
| JP2017206443A (ja) * | 2014-09-26 | 2017-11-24 | 宇部興産株式会社 | 置換ビアリール化合物及び他の医薬の組み合わせ |
| JP7032134B2 (ja) | 2015-07-09 | 2022-03-08 | 参天製薬株式会社 | ピリジルアミノ酢酸化合物を含有する予防及び／又は治療剤 |
| WO2018108627A1 (de) | 2016-12-12 | 2018-06-21 | Bayer Cropscience Aktiengesellschaft | Verwendung substituierter indolinylmethylsulfonamide oder deren salze zur steigerung der stresstoleranz in pflanzen |
| WO2019025153A1 (de) | 2017-07-31 | 2019-02-07 | Bayer Cropscience Aktiengesellschaft | Verwendung von substituierten n-sulfonyl-n'-aryldiaminoalkanen und n-sulfonyl-n'-heteroaryldiaminoalkanen oder deren salzen zur steigerung der stresstoleranz in pflanzen |
| JP7250685B2 (ja) * | 2017-09-29 | 2023-04-03 | 参天製薬株式会社 | ピリジルアミノ酢酸化合物を含有する医薬 |
| WO2019124487A1 (ja) | 2017-12-21 | 2019-06-27 | 参天製薬株式会社 | オミデネパグの組合せ |
| EP3733179A4 (en) | 2017-12-28 | 2021-09-15 | Santen Pharmaceutical Co., Ltd. | PHARMACEUTICAL PREPARATION CONTAINING A PYRIDYLAMINOACETIC ACID COMPOUND |
| CN118084895B (zh) * | 2024-02-28 | 2025-09-05 | 中国药科大学 | 一种一氧化氮供体型Omidenepag衍生物及其制备方法和应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991019300A1 (en) | 1990-06-08 | 1991-12-12 | Sps Technologies, Incorporated | Improved magnetic materials and process for producing the same |
| TW523506B (en) | 1996-12-18 | 2003-03-11 | Ono Pharmaceutical Co | Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients |
| UA59384C2 (uk) | 1996-12-20 | 2003-09-15 | Пфайзер, Інк. | Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі |
| UA67754C2 (uk) | 1997-10-10 | 2004-07-15 | Пфайзер, Інк. | Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти) |
| EA200000768A1 (ru) | 1998-01-27 | 2001-06-25 | Эвентис Фармасьютикалз Продактс Инк. | ЗАМЕЩЕННЫЕ ОКСОАЗАГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ ФАКТОРА Ха |
| AU2001290250A1 (en) | 2000-09-21 | 2002-04-02 | Ono Pharmaceutical Co. Ltd. | Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient |
| BR0211810A (pt) * | 2001-08-09 | 2004-08-24 | Ono Pharmaceutical Co | Derivados ácido carboxìlico e agente farmacêutico compreendendo os mesmos como ingrediente ativo |
| DE60118628T2 (de) | 2001-10-26 | 2007-02-15 | Allergan, Inc., Irvine | Omega-cycloalkyl 17-heteroaryl prostaglandin e2 analogen als ep2-rezeptor agonisten |
| HUP0500012A2 (hu) * | 2002-01-31 | 2005-04-28 | Pfizer Products Inc. | A (3-{[4-terc-butil-benzil)-(piridin-3-szulfonil)-amino]-metil}-fenoxi)-ecetsav metabolitjai és ezeket hatóanyagként tartalmazó gyógyszerkészítmények |
| WO2003074483A1 (en) | 2002-03-05 | 2003-09-12 | Ono Pharmaceutical Co., Ltd. | 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| AU2004216898A1 (en) | 2003-03-04 | 2004-09-16 | Pfizer Products Inc. | Use of EP2 selective receptor agonists in medical treatment |
| GB0329620D0 (en) | 2003-12-22 | 2004-01-28 | Pharmagene Lab Ltd | EP2 receptor agonists |
| WO2005072743A1 (ja) | 2004-01-30 | 2005-08-11 | Ono Pharmaceutical Co., Ltd. | 気管支拡張剤 |
| JP2007186424A (ja) | 2004-11-26 | 2007-07-26 | Ono Pharmaceut Co Ltd | 気管支拡張剤 |
| US7994196B2 (en) | 2004-02-12 | 2011-08-09 | Mitsubishi Tanabe Pharma Corporation | Indazole compound and pharmaceutical use thereof |
| EP1593671A1 (en) | 2004-03-05 | 2005-11-09 | Graffinity Pharmaceuticals AG | DPP-IV inhibitors |
| WO2006009876A2 (en) | 2004-06-17 | 2006-01-26 | Cengent Therapeutics, Inc. | Trisubstituted nitrogen modulators of tyrosine phosphatases |
| GB0415320D0 (en) * | 2004-07-08 | 2004-08-11 | Astrazeneca Ab | Novel compounds |
| CN101137653B (zh) | 2005-01-14 | 2012-05-09 | 弗·哈夫曼-拉罗切有限公司 | 作为mglur5拮抗剂的噻唑-4-甲酰胺衍生物 |
| US7829585B2 (en) | 2005-03-30 | 2010-11-09 | Eisai R&D Management Co., Ltd. | Antifungal agent containing pyridine derivative |
| WO2007014462A1 (en) | 2005-08-03 | 2007-02-08 | Merck Frosst Canada Ltd. | Ep4 receptor agonist, compositions and methods thereof |
| AU2006277786B2 (en) | 2005-08-09 | 2012-09-06 | Asterand Uk Acquisition Limited | EP2 receptor agonists |
| US7696235B2 (en) | 2005-08-29 | 2010-04-13 | Allergan, Inc. | EP2 receptor agonists for treating glaucoma |
| JP4583500B2 (ja) * | 2006-07-28 | 2010-11-17 | ファイザー・プロダクツ・インク | Ｅｐ２作動薬 |
| UA94953C2 (en) * | 2006-07-28 | 2011-06-25 | Пфайзер Продактс Инк. | Ep2 agonists |
| US8648097B2 (en) * | 2008-03-12 | 2014-02-11 | Ube Industries, Ltd. | Pyridylaminoacetic acid compound |
| ES2564010T3 (es) | 2009-03-30 | 2016-03-17 | Ube Industries, Ltd. | Composición farmacéutica para tratar o prevenir el glaucoma |
-
2009
- 2009-03-12 US US12/922,028 patent/US8648097B2/en active Active
- 2009-03-12 CA CA2718393A patent/CA2718393C/en active Active
- 2009-03-12 AU AU2009224329A patent/AU2009224329B2/en active Active
- 2009-03-12 PT PT09721163T patent/PT2264009T/pt unknown
- 2009-03-12 WO PCT/JP2009/054713 patent/WO2009113600A1/ja not_active Ceased
- 2009-03-12 HU HUE09721163A patent/HUE042839T2/hu unknown
- 2009-03-12 KR KR1020107022680A patent/KR101609001B1/ko active Active
- 2009-03-12 TR TR2019/04655T patent/TR201904655T4/tr unknown
- 2009-03-12 CN CN200980108500.4A patent/CN101970410B/zh active Active
- 2009-03-12 DK DK09721163.5T patent/DK2264009T3/en active
- 2009-03-12 JP JP2010502864A patent/JP5136640B2/ja active Active
- 2009-03-12 PL PL09721163T patent/PL2264009T3/pl unknown
- 2009-03-12 SI SI200931953T patent/SI2264009T1/sl unknown
- 2009-03-12 LT LTEP09721163.5T patent/LT2264009T/lt unknown
- 2009-03-12 HR HRP20190509TT patent/HRP20190509T1/hr unknown
- 2009-03-12 EP EP09721163.5A patent/EP2264009B1/en active Active
- 2009-03-12 CN CN201410213200.5A patent/CN103965099A/zh active Pending
- 2009-03-12 ES ES09721163T patent/ES2718813T3/es active Active
-
2012
- 2012-11-15 JP JP2012251011A patent/JP5545344B2/ja not_active Expired - Fee Related
-
2013
- 2013-12-16 US US14/108,029 patent/US20140113907A1/en not_active Abandoned
-
2014
- 2014-05-14 JP JP2014100287A patent/JP2014177476A/ja active Pending
-
2019
- 2019-03-28 CY CY20191100359T patent/CY1121543T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013063994A (ja) | 2013-04-11 |
| KR101609001B1 (ko) | 2016-04-04 |
| HRP20190509T1 (hr) | 2019-05-03 |
| AU2009224329A1 (en) | 2009-09-17 |
| CN101970410B (zh) | 2014-06-25 |
| ES2718813T3 (es) | 2019-07-04 |
| JP5545344B2 (ja) | 2014-07-09 |
| LT2264009T (lt) | 2019-04-25 |
| EP2264009A4 (en) | 2012-08-01 |
| JPWO2009113600A1 (ja) | 2011-07-21 |
| US8648097B2 (en) | 2014-02-11 |
| CN103965099A (zh) | 2014-08-06 |
| US20110054172A1 (en) | 2011-03-03 |
| US20140113907A1 (en) | 2014-04-24 |
| DK2264009T3 (en) | 2019-04-15 |
| CN101970410A (zh) | 2011-02-09 |
| KR20100123903A (ko) | 2010-11-25 |
| AU2009224329B2 (en) | 2013-11-07 |
| CY1121543T1 (el) | 2020-05-29 |
| TR201904655T4 (tr) | 2019-06-21 |
| CA2718393A1 (en) | 2009-09-17 |
| JP5136640B2 (ja) | 2013-02-06 |
| EP2264009A1 (en) | 2010-12-22 |
| PT2264009T (pt) | 2019-04-29 |
| EP2264009B1 (en) | 2019-03-06 |
| WO2009113600A1 (ja) | 2009-09-17 |
| CA2718393C (en) | 2015-06-16 |
| HUE042839T2 (hu) | 2019-07-29 |
| JP2014177476A (ja) | 2014-09-25 |
| SI2264009T1 (sl) | 2019-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT2264009T (lt) | Piridilaminoacto rūgšties junginys | |
| ZA201008096B (en) | Carboxylic acid compound | |
| GB0818033D0 (en) | Novel compound | |
| SI2192109T1 (sl) | Biciklični aminokislinski derivati | |
| GB0800035D0 (en) | Compounds | |
| GB0804989D0 (en) | Compound | |
| ZA201000869B (en) | Phenylacetic acid compound | |
| GB0803494D0 (en) | Compound | |
| IL207035A0 (en) | Benzylpiperizine compound | |
| IL206524A0 (en) | 4-dimethylminobutyric acid derivatives | |
| GB0800367D0 (en) | Compounds | |
| GB0823316D0 (en) | Compound | |
| GB0801220D0 (en) | Compounds | |
| GB0801265D0 (en) | Compounds | |
| GB0806005D0 (en) | Compound | |
| GB0806844D0 (en) | Compound | |
| GB0812580D0 (en) | Compound | |
| GB0807160D0 (en) | Compound | |
| GB0820915D0 (en) | Compound | |
| GB0820916D0 (en) | Compound | |
| GB0820918D0 (en) | Compound | |
| GB0815806D0 (en) | Compound | |
| GB0822635D0 (en) | Compound | |
| GB0807158D0 (en) | Compound | |
| GB0820919D0 (en) | Compound |